Trisol Medical Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Later Stage VC
- Investors
-
8
Trisol Medical General Information
Description
Developer of a medical device designed to treat tricuspid regurgitation. The company's transcatheter tricuspid replacement valve is constructed from a nitinol frame with specially designed leaflets that eliminate tricuspid regurgitation while preserving the right ventricle function, enabling patients to benefit from the comprehensive treatment of Tricuspid Regurgitation and RV dysfunction.
Contact Information
Website
www.trisol-medical.comCorporate Office
- 7 Ha'kidma Street
- Yokneam
- Israel
Corporate Office
- 7 Ha'kidma Street
- Yokneam
- Israel
Trisol Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 28-Jul-2023 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 14-Dec-2021 | Completed | Generating Revenue | |||
| 8. Angel (individual) | 01-Sep-2021 | Completed | Clinical Trials - General | |||
| 7. Grant | 09-Oct-2019 | Completed | Clinical Trials - General | |||
| 6. Early Stage VC | 15-Mar-2019 | Completed | Clinical Trials - General | |||
| 5. Early Stage VC (Series A) | 01-Apr-2018 | Completed | Clinical Trials - General | |||
| 4. Seed Round | Completed | Startup | ||||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup | |||
| 1. Grant | 01-Jul-2016 | $27.3M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Trisol Medical Patents
Trisol Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025253388-A1 | Prosthetic valve | Pending | 06-Jun-2024 | ||
| EP-4422553-A1 | Valve delivery system and methods | Pending | 31-Oct-2021 | ||
| EP-4422553-A4 | Valve delivery system and methods | Pending | 31-Oct-2021 | ||
| US-20250000650-A1 | Valve delivery system and methods | Pending | 31-Oct-2021 | ||
| WO-2023073686-A1 | Valve delivery system and methods | Inactive | 31-Oct-2021 | A61F2/2436 |
Trisol Medical Signals
Trisol Medical Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BayMed Venture Partners | Venture Capital | Minority | ||
| Katao Venture Partners | Venture Capital | Minority | ||
| Club 100 plus | Angel Group | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Bass Investment | Venture Capital | Minority |
Trisol Medical FAQs
-
When was Trisol Medical founded?
Trisol Medical was founded in 2016.
-
Where is Trisol Medical headquartered?
Trisol Medical is headquartered in Yokneam, Israel.
-
What is the size of Trisol Medical?
Trisol Medical has 26 total employees.
-
What industry is Trisol Medical in?
Trisol Medical’s primary industry is Therapeutic Devices.
-
Is Trisol Medical a private or public company?
Trisol Medical is a Private company.
-
What is Trisol Medical’s current revenue?
The current revenue for Trisol Medical is .
-
How much funding has Trisol Medical raised over time?
Trisol Medical has raised $5.76M.
-
Who are Trisol Medical’s investors?
BayMed Venture Partners, Katao Venture Partners, Club 100 plus, European Innovation Council, and Bass Investment are 5 of 8 investors who have invested in Trisol Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process